Page last updated: 2024-10-25

clioquinol and Actinic Reticuloid Syndrome

clioquinol has been researched along with Actinic Reticuloid Syndrome in 2 studies

Clioquinol: A potentially neurotoxic 8-hydroxyquinoline derivative long used as a topical anti-infective, intestinal antiamebic, and vaginal trichomonacide. The oral preparation has been shown to cause subacute myelo-optic neuropathy and has been banned worldwide.
5-chloro-7-iodoquinolin-8-ol : A monohydroxyquinoline that is quinolin-8-ol in which the hydrogens at positions 5 and 7 are replaced by chlorine and iodine, respectively. It has antibacterial and atifungal properties, and is used in creams for the treatment of skin infections. It has also been investigated as a chelator of copper and zinc ions for the possible treatment of Alzheimer's disease.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Placzek, M1
Krosta, I1
Gaube, S1
Eberlein-König, B1
Przybilla, B1
Rivara, G1
Barile, M1
Guarrera, M1

Other Studies

2 other studies available for clioquinol and Actinic Reticuloid Syndrome

ArticleYear
Evaluation of phototoxic properties of antimicrobials used in topical preparations by a photohaemolysis test.
    Acta dermato-venereologica, 2005, Volume: 85, Issue:1

    Topics: Anti-Infective Agents; Clioquinol; Dose-Response Relationship, Drug; Dose-Response Relationship, Rad

2005
Photosensitivity in a patient with contact allergic dermatitis from clioquinol.
    Photodermatology, photoimmunology & photomedicine, 1991, Volume: 8, Issue:5

    Topics: Chronic Disease; Clioquinol; Dermatitis, Contact; Humans; Male; Middle Aged; Patch Tests; Photosensi

1991